Zhejiang Huakang Pharmaceutical Co., Ltd.

SHSE:605077 株式レポート

時価総額：CN¥4.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Zhejiang Huakang Pharmaceutical マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Deshui Chen

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権15.9%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Sep 26
Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Jul 02
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

May 28
Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

CEO（最高経営責任者

Deshui Chen (54 yo)

no data

在職期間

CN¥1,505,800

報酬

Mr. Deshui Chen is Chairman of the Board & GM of Zhejiang Huakang Pharmaceutical Co. Ltd.